Drug Eluting Stenting and Short Dual Antiplatelet Therapy for Preventing Recurrent Stroke in Vert… (NCT06683300) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Drug Eluting Stenting and Short Dual Antiplatelet Therapy for Preventing Recurrent Stroke in Vertebral Stenosis Registry Study
China520 participantsStarted 2024-11
Plain-language summary
This is a prospective, multi-center, registry study exploring the duration of dual antiplatelet therapy (DAPT) after drug-eluting stent(DES) treatment of symptomatic vertebral artery atherosclerotic stenosis. The trial will be conducted in approximately 30 interventional neurology centers in China.
Currently, there is no consensus regarding the duration of DAPT after drug-eluting stent treatment for vertebral artery stenosis(VAS). The objective of this study is to standardize clinical medication by shortening the duration of DAPT, thereby reducing the bleeding risk and medication burden for patients, while ensuring that there is no increase in ischemic events.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥18 years old, gender unlimited;
✓. Based on clinical and imaging evidence, the investigators identified patients with symptomatic vertebral atherosclerotic stenosis who met the indications for the placement of drug-eluting vertebral artery stents;
✓. Patients or their guardians sign informed consent.
Exclusion criteria
✕. Severe coagulation dysfunction, serious uncontrolled infection, serious systemic disease, uncontrolled hypertension, etc., are not suitable for surgery;
✕. Patients with aneurysms that cannot be treated in advance or at the same time or are not suitable for surgery;
✕. Myocardial infarction or large-scale cerebral infarction occurred within 2 weeks;
✕. Combined with atrial fibrillation, or accompanied by serious heart, liver, kidney and lung diseases;
✕. Interventional or surgical procedures are planned within 90 days;
✕
What they're measuring
1
Occurrence of ischemic stroke in the territory of the target artery within 1 year